Tunable Polymer Embolic Implant for Vascular Occlusion
Source abstract
Abstract
In this study, we have developed a tunable polymer vascular embolic implant (TPVEI) with adjustable precipitation rates allowing for personalized, controlled vascular occlusion depths. We hypothesized that reducing the water miscibility of the solvent would result in slower TPVEI precipitation, leading to distal vascular occlusion. To investigate homogeneous vascular distribution and occlusion control, the TPVEI was directly injected into the portal vein of a rat and imaged with microCT. Changing the solvent ratio of NMP/BB from 100/0 to 50/50 showed a significant (p < 0.05) decrease in vessel size occluded from 675 ± 20 to 170 ± 25 μm, respectively. The 60/40 (NMP/BB) formulation was able to occlude several branches throughout the whole liver, displaying a homogeneous vasculature distribution. Broadband Doppler ultrasound validated that there was complete portal vein occlusion after embolization with all materials. These findings suggest that adjusting the solvent polarity allows embolization control and with appropriate optimization, phase-inverting embolics could be used better to control depth of occlusion for endovascular therapies.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Organ Transplantation Techniques and Outcomes · Liver Disease and Transplantation · MRI in cancer diagnosis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. 10.3174/ajnr.A131410.3174/ajnr.A1314 ↗
2. 10.1016/j.jvir.2017.07.02010.1016/j.jvir.2017.07.020 ↗
3. 10.1126/scitranslmed.aah553310.1126/scitranslmed.aah5533 ↗
4. 10.1021/acs.molpharmaceut.6b0032510.1021/acs.molpharmaceut.6b00325 ↗
5. 10.1016/j.diii.2014.11.03010.1016/j.diii.2014.11.030 ↗
6. 10.1055/s-0028-108593010.1055/s-0028-1085930 ↗
7. 10.1007/s00270-007-9280-610.1007/s00270-007-9280-6 ↗
8. Wáng Y.-X. J. · Chin. J. Cancer Res. · 2015 · 27 · 96
9. 10.1007/s00234-008-0382-x10.1007/s00234-008-0382-x ↗
10. 10.1016/j.biomaterials.2015.04.01510.1016/j.biomaterials.2015.04.015 ↗
11. 10.1007/s00270-006-0071-210.1007/s00270-006-0071-2 ↗
12. 10.7150/thno.418110.7150/thno.4181 ↗
13. 10.3109/03639045.2012.66095210.3109/03639045.2012.660952 ↗
14. 10.1007/s00270-013-0567-510.1007/s00270-013-0567-5 ↗
15. 10.3748/wjg.14.483410.3748/wjg.14.4834 ↗
16. 10.4155/tde-2015-000810.4155/tde-2015-0008 ↗
17. 10.1016/j.ejpb.2004.03.00310.1016/j.ejpb.2004.03.003 ↗
18. 10.1016/j.jconrel.2013.08.02410.1016/j.jconrel.2013.08.024 ↗
19. 10.1177/109158181772899610.1177/1091581817728996 ↗
20. 10.1016/S0090-4295(02)02396-810.1016/S0090-4295(02)02396-8 ↗
21. 10.1016/j.fct.2005.04.00710.1016/j.fct.2005.04.007 ↗
22. 10.1016/j.jconrel.2010.01.00110.1016/j.jconrel.2010.01.001 ↗
23. 10.1002/jps.2455810.1002/jps.24558 ↗
24. 10.1021/acsami.7b1975510.1021/acsami.7b19755 ↗
25. 10.1016/j.jconrel.2016.10.00910.1016/j.jconrel.2016.10.009 ↗
26. 10.1016/j.jconrel.2010.08.02010.1016/j.jconrel.2010.08.020 ↗
27. 10.1039/C6RA27676H10.1039/C6RA27676H ↗
28. 10.1016/0160-5402(89)90066-110.1016/0160-5402(89)90066-1 ↗
29. 10.1016/j.ultras.2003.12.02710.1016/j.ultras.2003.12.027 ↗
30. 10.1016/0011-9164(95)00076-310.1016/0011-9164(95)00076-3 ↗
31. 10.1016/j.biomaterials.2016.06.06410.1016/j.biomaterials.2016.06.064 ↗
32. 10.1590/S0102-6720201400040001210.1590/S0102-67202014000400012 ↗
33. 10.1590/S0102-8650200900010000910.1590/S0102-86502009000100009 ↗